Complete Heart Block Associated with Regadenoson: a Real Side Effect

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2012 Aug 24

PMID 22915132

Citations 6

Authors

Anil Pandit

Samuel Unzek Freiman

Affiliations

Soon will be listed here.

Citing Articles

Adverse effects associated with regadenoson myocardial perfusion imaging.

Andrikopoulou E, Hage F J Nucl Cardiol. 2018; 25(5):1724-1731.

PMID: 29468467 DOI: 10.1007/s12350-018-1218-7.

Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis.

Andrikopoulou E, Morgan C, Brice L, Bajaj N, Doppalapudi H, Iskandrian A J Nucl Cardiol. 2017; 26(2):616-628.

PMID: 29043556 PMC: 5904011. DOI: 10.1007/s12350-017-1081-y.

Regadenoson-induced complete heart block and asystole: A real possibility nuclear laboratories should be aware of.

Kureshi F, Abdallah M, Bateman T J Nucl Cardiol. 2016; 24(6):2019-2024.

PMID: 28000148 DOI: 10.1007/s12350-016-0755-1.

Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Dilsizian V, Gewirtz H, Paivanas N, Kitsiou A, Hage F, Crone N J Nucl Cardiol. 2015; 22(6):1198-213.

PMID: 25975944 DOI: 10.1007/s12350-015-0141-4.

Regadenoson for myocardial perfusion imaging: Is it safe?.

Hage F J Nucl Cardiol. 2014; 21(5):871-6.

PMID: 24939324 DOI: 10.1007/s12350-014-9922-4.

References

Trochu J, Zhao G, Post H, Xu X, Belardinelli L, Belloni F . Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging. J Cardiovasc Pharmacol. 2002; 41(1):132-9. DOI: 10.1097/00005344-200301000-00017. View

Iskandrian A, Bateman T, Belardinelli L, Blackburn B, Cerqueira M, Hendel R . Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007; 14(5):645-58. DOI: 10.1016/j.nuclcard.2007.06.114. View